850
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment

, , , , &
Pages 897-906 | Received 26 Mar 2013, Accepted 29 Jul 2013, Published online: 05 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (15)

Jixin Chen, Shuqi Chen, Huiyan Luo, Wanyin Wu & Sumei Wang. (2023) The application of arsenic trioxide in cancer: An umbrella review of meta-analyses based on randomized controlled trials. Journal of Ethnopharmacology 316, pages 116734.
Crossref
Diego D. Santos, Gisela R.S. Sasso, Nycole M. Belote, Rafael André da Silva, Izabella Lice, Rebeca D. Correia-Silva, Fernanda T. Borges, Adriana A.F. Carbonel & Cristiane D. Gil. (2023) Galectin-3 is a key hepatoprotective molecule against the deleterious effect of cisplatin. Life Sciences 318, pages 121505.
Crossref
Prarthana Gopinath, Aparna Natarajan, Amritha Sathyanarayanan, Sridevi Veluswami & Gopal Gopisetty. (2022) The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets. Gene 815, pages 146137.
Crossref
Diego José Laderach & Daniel Compagno. (2021) Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure. Cancers 13:18, pages 4529.
Crossref
T. Jeethy Ram, Asha Lekshmi, Thara Somanathan & K. Sujathan. (2021) Galectin-3: A factotum in carcinogenesis bestowing an archery for prevention. Tumor Biology 43:1, pages 77-96.
Crossref
Xin Gu, Hongxue Meng, Jia Wang, Ruitao Wang, Muyang Cao, Siyu Liu, Hui Chen & Yangyang Xu. (2021) Hypoxia contributes to galectin-3 expression in renal carcinoma cells. European Journal of Pharmacology 890, pages 173637.
Crossref
Pilar Navarro, Neus Martínez-Bosch, Ada G. Blidner & Gabriel A. Rabinovich. (2020) Impact of Galectins in Resistance to Anticancer Therapies. Clinical Cancer Research 26:23, pages 6086-6101.
Crossref
Yinling Zhu, Siyao Dong, Yanjiao Zhu, Yichuan Zhao & Yan Xu. (2019) Identification of cancer prognosis-associated lncRNAs based on the miRNA-TF co-regulatory motifs and dosage sensitivity. Molecular Omics 15:5, pages 361-373.
Crossref
Bojana Stojanovic, Jelena Milovanovic, Aleksandar Arsenijevic, Bojan Stojanovic, Ivana Strazic Geljic, Nebojsa Arsenijevic, Stipan Jonjic, Miodrag L. Lukic & Marija Milovanovic. (2019) Galectin-3 Deficiency Facilitates TNF-α-Dependent Hepatocyte Death and Liver Inflammation in MCMV Infection. Frontiers in Microbiology 10.
Crossref
Brenda C. Minatel, Adam P. Sage, Christine Anderson, Roland Hubaux, Erin A. Marshall, Wan L. Lam & Victor D. Martinez. (2018) Environmental arsenic exposure: From genetic susceptibility to pathogenesis. Environment International 112, pages 183-197.
Crossref
Francesca Saccon, Mariele Gatto, Anna Ghirardello, Luca Iaccarino, Leonardo Punzi & Andrea Doria. (2017) Role of galectin-3 in autoimmune and non-autoimmune nephropathies. Autoimmunity Reviews 16:1, pages 34-47.
Crossref
Yangyang Xu, Changfu Li, Jiahang Sun, Jingshu Li, Xin Gu & Wanhai Xu. (2016) Antitumor effects of galectin-3 inhibition in human renal carcinoma cells. Experimental Biology and Medicine 241:13, pages 1365-1373.
Crossref
Aleksandar Arsenijevic, Marija Milovanovic, Jelena Milovanovic, Bojana Stojanovic, Natasa Zdravkovic, Patrick S.C. Leung, Fu-Tong Liu, M. Eric Gershwin & Miodrag L. Lukic. (2016) Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens. Scientific Reports 6:1.
Crossref
ShuYan Liu, ZhaoYang Wang & JunYing Miao. (2016) Potential roles of annexin A7 GTPase in autophagy, senescence and apoptosis. RSC Advances 6:115, pages 114587-114592.
Crossref
Yves St-Pierre. (2014) Intracellular galectins in cancer cells: Potential new targets for therapy (Review). International Journal of Oncology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.